Interestingly, these findings were in line with a later study that found that intravenously injecting NK‐92‐scFv (FRP5)‐zeta cells expressing HER2‐specific CAR might reduce tumour volume in a xenograft HER2‐representing breast metastasis model in‐vivo. The gene discussed is ERBB2; the disease is neoplasm.